Kopkan Libor, Husková Zuzana, Vanourková Zdenka, Thumová Monika, Skaroupková Petra, Malý Jan, Kramer Herbert J, Dvorák Pavel, Cervenka Ludek
Department for Experimental Medicine, Institute for Clinical and Experimental Medicine, 1958/9 Vídenská, CZ-140 21 Prague 4, Czech Republic.
Vascul Pharmacol. 2009 Aug-Sep;51(2-3):175-81. doi: 10.1016/j.vph.2009.06.001. Epub 2009 Jun 16.
Results of our previous studies have suggested that enhanced generation of superoxide (O2(-)) may contribute to the pathophysiology of hypertension in Ren-2 transgenic rats (TGR). The present study was performed to evaluate in TGR the effects of chronic treatment with the O2(-) scavenger tempol and the antioxidant apocynin on the development of hypertension. Systolic blood pressure (SBP) was monitored from 30 to 99 days of age in TGR and in normotensive Hannover Sprague-Dawley (HanSD) rats. At the end of the experiment, urinary protein and 8-isoprostane excretion were determined and angiotensin II (ANG II) and malondialdehyde (MDA) levels were measured in kidney and cardiac tissues. Cardiac hypertrophy was assessed as the ratio of left heart ventricle weight to tibia length (LVW/TL). Although tempol and apocynin treatment in TGR significantly decreased 8-isoprostane excretion and MAD tissue concentrations as compared with untreated TGR, it did not alter the course of SBP, LVW/TL ratio, proteinuria or ANG II levels that were enhanced as compared with HanSD rats. Our data suggest that the development of hypertension in TGR is clearly ANG II-dependent but the contribution of oxidative stress to the development of hypertension in this model appears to be negligible.
我们之前研究的结果表明,超氧化物(O2(-))生成增加可能与Ren-2转基因大鼠(TGR)高血压的病理生理学有关。本研究旨在评估在TGR中用超氧化物清除剂tempol和抗氧化剂载脂蛋白对高血压发展的慢性治疗效果。在TGR和正常血压的汉诺威-斯普拉格-道利(HanSD)大鼠中,从30日龄到99日龄监测收缩压(SBP)。实验结束时,测定尿蛋白和8-异前列腺素排泄,并测量肾脏和心脏组织中的血管紧张素II(ANG II)和丙二醛(MDA)水平。以左心室重量与胫骨长度之比(LVW/TL)评估心脏肥大。尽管与未治疗的TGR相比,TGR中tempol和载脂蛋白治疗显著降低了8-异前列腺素排泄和MAD组织浓度,但与HanSD大鼠相比,它并未改变升高的SBP、LVW/TL比值、蛋白尿或ANG II水平的进程。我们的数据表明,TGR中高血压的发展明显依赖于ANG II,但在该模型中氧化应激对高血压发展的贡献似乎可以忽略不计。